Seeking Alpha EN

Vaxart GAAP EPS of $0.07 beats by $0.28, revenue of $237.2M beats by $34.5M

Mar 12, 2026 &03111212202631; 20:11 UTC seekingalpha.com Trending 3/5

Read original on seekingalpha.com ↗

↗

Positive for markets

Sentiment score: +75/100

High impact Immediate effect (hours)

WHAT THIS MEANS

Vaxart delivered a significant earnings beat with GAAP EPS of $0.07 exceeding expectations by $0.28, while revenue of $237.2M surpassed estimates by $34.5M, indicating strong operational performance and market demand.

AI CONFIDENCE

85% Very high

SENTIMENT GAUGE

NEWS POWER SCORE

AFFECTED ASSETS

↑

VXRT

VXRTStock

Expected to rise

Substantial earnings beat with EPS exceeding by $0.28 and revenue beat of $34.5M demonstrates strong execution and revenue growth

PRICE HISTORY

Loading chart...

⚡ SUGGESTED ACTION

Consider initiating or adding to long positions on VXRT given the substantial earnings beat. Monitor for follow-up guidance and analyst upgrades which typically follow such significant outperformance.

KEY SIGNALS

Significant EPS beat of 400% above expectationsRevenue beat of 17% above consensusStrong operational executionPositive earnings surprise momentum

SECTORS INVOLVED

HealthcareBiotechnologyPharmaceuticals

Analysis generated on Mar 16, 2026 at 16:22 UTC

Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by Seeking Alpha. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Vaxart GAAP EPS of $0.07 beats by $0.28, revenue of $237.2M beats by $34.5M

RELATED INTELLIGENCE